FDA: July 23, 2013 The U.S. Food and Drug Administration is taking action to remove from the market illegal products, including some labeled as dietary supplements, that claim to mitigate, treat, cure or prevent diabetes and related complications. The agency recently issued letters warning 15 companies that the sale of their illegally marketed diabetes products […]
Diabetes Care: July 22, 2013 OBJECTIVE This study used qualitative interviews with black and Latino participants with diabetes to further understanding about types of foods eaten, food preparation, sources of foods and meals, communication with providers, and effects of race and ethnicity on eating in this population. RESEARCH DESIGN AND METHODS Researchers recruited black and Latino adults from […]
The Journal of Clinical Endocrinology & Metabolism: July 19, 2013 Context: Although overweight and obese African-Americans (AA) have less visceral adipose tissue (VAT) and liver fat (LF) than Hispanics, they have a similar risk for type 2 diabetes (T2D). Objective: We examined ethnic differences in the association between VAT and LF with risk factors for T2D to help […]
Healthday: July 24, 2013 Diabetic children at higher risk for retinopathy, which can lead to blindness, studies show WEDNESDAY, July 17 (HealthDay News) — Black American children with the greatest risk for an eye disease caused by type 1 diabetes are the least likely to have received an eye exam, a new study finds. Retinopathy is […]
The Diabetes Educator: July 16, 2013 Predictors of Participation in a Community Health Worker Diabetes Management Intervention With African American and Latino Adults Purpose The purpose of the study was to determine the effects of gender on participation in a community-based, culturally tailored diabetes lifestyle intervention, led by trained community health workers (CHW) and conducted with African […]
The Diabetes EducatorJuly/August 2013 Purpose The purpose of this study is to examine the effectiveness of a culturally specific pilot clinic for Asian Americans (AA) in reaching glycemic target and to characterize factors affecting the attainment of glycemic control in comparison with white counterparts. Methods This electronic health record review included all new AA patients with type […]
Diabetes Care: July 17, 2013 The 2-year interim analysis of the MIND.IT study: a cluster randomized trial OBJECTIVE To evaluate the feasibility and effectiveness of an intensive, multifactorial cardiovascular risk reduction intervention in a clinic-based setting. RESEARCH DESIGN AND METHODS The study was a pragmatic, cluster randomized trial, with the diabetes clinic as the unit of randomization. Clinics […]
The Lancet, Early Online Publication, 12 July 2013 Background Sodium—glucose cotransporter 2 (SGLT2) inhibitors improve glycaemia in patients with type 2 diabetes by enhancing urinary glucose excretion. We compared the efficacy and safety of canagliflozin, an SGLT2 inhibitor, with glimepiride in patients with type 2 diabetes inadequately controlled with metformin. Methods We undertook this 52 […]
Diabetes Care: July 11, 2013 The OPTIMISE randomized, controlled trial OBJECTIVE To assess prospectively the effect of benchmarking on quality of primary care for patients with type 2 diabetes by using three major modifiable cardiovascular risk factors as critical quality indicators. RESEARCH DESIGN AND METHODS Primary care physicians treating patients with type 2 diabetes in six European countries […]
Appliedclinicaltrialsonline: Jun 1, 2013 Increased competition to bring the next blockbuster drug to the market has created an urgency to improve the efficiency of every facet of drug development. Subject recruitment, or lack thereof, has been considered to be one of the major factors delaying study completion. Recruiting patients in an efficient manner has become critical […]
 |
